Weak Trigger
now
Reports phase 2 trial data for oral obesity drug 'VK2735' showing 5.3% weight loss in 28 days; triggers intense Wall Street M&A buyout rumors.
24h Trigger History
No history available
No trigger updates found for this ticker in the last 24 hours.
| Advertisement |